Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair

  1. Chang-Goo Huh*,
  2. Valentina M. Factor*,
  3. Aránzazu Sánchez,
  4. Koichi Uchida,
  5. Elizabeth A. Conner, and
  6. Snorri S. Thorgeirsson
  1. Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive MSC 4262, Building 37, Room 4146A, Bethesda, MD 20892-4262
  1. Edited by George F. Vande Woude, Van Andel Research Institute, Grand Rapids, MI, and approved January 16, 2004 (received for review September 22, 2003)

Abstract

Hepatocyte growth factor/scatter factor c-met signaling pathway is of central importance during development as well as in tumorigenesis. Because homozygous null mice for either hgf/sf or c-met die in utero, we used Cre/loxP-mediated gene targeting to investigate the function of c-met specifically in the adult liver. Loss of c-met appeared not to be detrimental to hepatocyte function under physiological conditions. Nonetheless, the adaptive responses of the liver to injury were dramatically affected. Mice lacking c-met gene in hepatocytes were hypersensitive to Fas-induced apoptosis. When injected with a low dose of anti-Fas antibody, the majority of these mice died from massive apoptosis and hemorrhagic necrosis, whereas all wild-type mice survived with signs of minor injury. After a challenge with a single necrogenic dose of CCl4, c-met conditional knockout mice exhibited impaired recovery from centrolobular lesions rather than a deficit in hepatocyte proliferation. The delayed healing was associated with a persistent inflammatory reaction, over-production of osteopontin, early and prominent dystrophic calcification, and impaired hepatocyte scattering/migration into diseased areas. These studies provide direct genetic evidence in support of the critical role of c-met in efficient liver regeneration and suggest that disruption of c-met affects primarily hepatocyte survival and tissue remodeling.

Footnotes

  • To whom correspondence should be addressed. E-mail: snorri_thorgeirsson{at}nih.gov.

  • * C.-G.H. and V.M.F. contributed equally to this work.

  • This paper was submitted directly (Track II) to the PNAS office.

  • Abbreviations: HGF/SF-Met, hepatocyte growth factor/scatter factor c-met signaling pathway; rhHGF, recombinant human HGF; AlbCre, albumin-Cre; PB, phenobarbital; PH, partial hepatectomy; uPA, urokinase-type plasminogen activator.

« Previous | Next Article »Table of Contents